The neuraminidase (NA) gene of influenza virus A/FPV/ Rostock/34 virus (H7N1) was cloned and expressed in Sf9 cells using a baculovirus vector. The expression product had the expected molecular mass and showed neuraminidase activity. NA expressed in St9 cells also showed haemagglutinating activity as indicated by its ability to induce haemadsorption of chicken red blood cells. Haemadsorption depended on the presence of neuraminic acid on the erythrocytes, but was not blocked by 2-deoxy-2,3-dehydro-N-acetylneuraminic acid, a specific inhibitor of the enzymatic activity. These observations suggest that the N1 neuraminidase has two distinct reactive sites: a catalytic site and a receptor binding site. This concept was confirmed by site-directed mutagenesis which showed that the haemadsorbing activity of FPV NA was abolished when amino acids located on two surface loops at the putative binding site were exchanged. Substitutions on either of the two loops were sufficient for this effect. The mutated NAs retained full neuraminidase activity. In contrast, a mutated NA lacking neuraminidase activity still had haemadsorbing activity.
Introduction
Unlike paramyxoviruses (Scheid & Choppin, 1974a, b; Scheid et at., 1972) and influenza C virus (Herrler et al., 1988; Vlasak et al., 1987) , which have haemagglutinating and neuraminidase activities on a single glycoprotein, influenza A and B viruses have different proteins for each activity. The haemagglutinin (HA) provides the receptorbinding function, whereas the neuraminidase (NA) destroys the cellular receptor N-acetylneuraminic acid (NANA) which allows the virus to elute from infected cells and prevents self-aggregation (Palese et al., 1974) .
Influenza virus NA of the N9 subtype has previously been reported to possess haemagglutinating activity which is fourfold higher than that of H3 HA (Laver et al., 1984) . Subsequently, this additional activity was demonstrated for other N9 NAs, and a binding site separate from the catalytic centre was postulated when escape mutants obtained with monoclonal antibodies were analysed . These results suggested the existence of a shallow pocket formed by two surface loops on the rim of the deep pocket representing the catalytic centre. Furthermore, the creation of a haemagglutinating site on an N2 NA by site-directed mutagenesis was recently described (Nuss & * Author for correspondence. Fax +49 6421 288962. e-mail KLENK@mailer.uni-marburg.de Air, 1991) . Since the three-dimensional structures of N2 and N9 NA have been shown to be very similar Varghese et al., 1992) , the chosen amino acid exchanges in these mutated N2s imitated the N9 sequence of the two surface loops thought to form the haemagglutinating site. Expression of the mutated sequences in recombinant vaccinia and simian virus 40 viruses demonstrated that N2 could only acquire haemagglutinating activity when both loops had the N9 sequence.
This study presents data which demonstrate the ability of an N1 subtype neuraminidase to agglutinate red blood cells (RBCs), a feature that was thought to be unique for the N9 NA until now. The haemagglutinating activity of FPV NA was analysed by binding of RBCs to Sf9 cells expressing NA from a baculovirus vector. The structural prerequisites of the haemagglutinating activity of FPV NA were investigated also.
Methods

Cells and viruses.
The Spodopterafrugiperda cell line SIP was used for infection with authentic or recombinant Autographa californica nuclear polyhedrosis virus (AcNPV). The methods used are detailed elsewhere (Kuroda et al., 1986 (Kuroda et al., , 1991 .
Cloning. For cloning, the NA gene from influenza virus A/FPV/ Rostock/34 (H7NI) was isolated from vRNA. Firstly, transcription from vRNA (3 ~tg) into cDNA was performed with reverse transcriptase for the first DNA strand using the upstream PCR primer (see below). This single-stranded DNA was then completed to double-stranded 0001-3072 © 1995 SGM DNA and further multiplied by PCR with a commercial kit [GeneAmp PCR Reagent kit with AmpliTaq (Perkin-Elmer Cetus)] for 30 cycles using the oligonucleotides AGCAAAAGCAGGAGTTCAAAATGA as an upstream primer and TAGAAACAAGGAGTTTTTTTGAAC as a downstream primer. Denaturation was done at 93 °C, annealing at 60 °C and elongation at 72 °C -each step for 1 min. NA-specific DNA was isolated from the reaction mixture after separation on an agarose gel, ligated to EcoRI-linkers, and cloned into the EcoRI site of the plasmid pUC19 using standard procedures. The fragment was then recloned into the EcoRI site of the baculovirus vector pVL1393.
Oligonucleotide-directed mutagenesis. The NA cDNA was isolated from pUC19-NA by digestion with EcoRI and was cloned into the replicative form DNA of M 13mpl 8 using standard techniques in such a manner that the coding strand of the NA cDNA was packaged into progeny M 13mpl 8 phages. Oligonucleotide-directed mutagenesis was done with a commercially available kit (Amersham) based on the phosphorothioate method (Taylor et al., 1985) using single-strand DNA of M 13mp 18-NA as a template. M 13mp 18-NA phages with only the desired mutation in the NA gene were selected by sequencing the single-strand DNA by the chain-termination method (Sanger et al., 1977) . The oligonucleotide primers used for mutagenesis and sequencing are available upon request. Primers 419R, 501R and 1066R create amino acid exchanges in FPV NA at positions 130 (R to K), 157 (W to S) and 345 (S to L), respectively (N1 numbering). Primer 1161R makes three amino acid changes at positions 375-377 (TDW to DNR). Mutated NA genes obtained from the phage replicative form of M 13mp 18-NA were isolated with EcoRI and ligated into the EcoRI site of the baculovirus vector pVL1393 for expression in Sf9 cells. The correct insertion of the NA cDNA for expression was checked by analytical digestion with PstI and the nucleotide sequences of the mutated NA genes were also verified.
Transfection of SJ9 cells. The pVL1393 plasmids containing NA genes under the control of the polyhedrin promoter were transfected in Sf9 cells together with wild-type vDNA (Invitrogen) using Lipofectin (BRL) as described by the manufacturer. Four days later, recombinant baculoviruses expressing NA were selected by three rounds of plaque purification.
Metabolic labelling and immunoprecipitation. Labelling with
[aSS]methionine (Amersham) and lysis for immunoprecipitation were performed as described previously (Kretzschmar et al., 1992) using an FPV NA-specific polyclonal antiserum.
Immunofluorescence assay. Sf9 cells grown on coverslips were infected with recombinant virus and incubated for 2 days at 27 °C. The cells were fixed with 3-7 % paraformaldehyde, incubated with 0.1 M-glycine in PBS for 5 rain, washed with PBS and air-dried. The cells were then incubated with a 1 : 100 dilution of a murine monoclonal NA-specific antibody (a gift of Dr H. Becht, Giel3en, Germany) for 60 min at room temperature. After washing with PBS, rhodamine-conjugated F(ab')2 fragment immunoglobulin (Dianova) was adsorbed to the cells for 60 min at room temperature. Excess antibody was washed off with PBS, and the cells were mounted in 100% glycerol. Cells were examined under a Zeiss Axiophot microscope. Results were recorded photographically.
Neuraminidase and neuraminidase inhibition assays. Two days postinfection (p.i.) with recombinant baculovirus, cells obtained from a 3.2 cm Petri dish were washed with PBS, resuspended in 100 gl PBS, sonicated for 1 s, and tested in various concentrations for NA activity using 0.2 gM-4-methylumbelliferyl g-D-N-acetylneuraminic acid (Sigma) as a substrate in 0.1 M-sodium acetate buffer, pH 5.5, in a total volume of 0-1 ml. The reaction was stopped after 10 rain at 37 °C by addition of 0-9 ml 0-133 M-glycine buffer, pH 10, containing 60 mMNaC1 and 40 mM-Na2CO a (Roggentin et al., 1987) . The fluorescence of released 4-methylumbelliferone was determined in a Perkin Elmer (LS-5B) luminescence spectrometer using excitation at 365 nm and emission at 450 nm. The corresponding enzymatic activity was determined by establishing a calibration curve using Vibrio eholerae neuraminidase (Behring) of known enzymatic activity. One U liberates 1 gmol N-acetylneuraminic acid from human gl-glycoprotein (10 mg/ml) in 1 min at 37 °C.
When the substrate specificity of NA was determined, reaction mixtures (50 gl) contained 1 gl Sf9 cell lysate (obtained as described above) or 1 gl FPV as a control and 6'-N-acetylneuraminyl-lactose or 3'-N-acetylneuraminyl-lactose (Sigma) (each 0"15mM). After incubation at 37 °C for 30 min, samples were monitored for liberated sialic acid using the periodate thiobarbituric acid method (Aymard-Henry et al., 1973) . Results were recorded by measuring the absorbance at 549 nm.
Samples for inhibition assays of NA activity (Meindl & Tuppy, 1969) were preincubated for 10 min on ice with the indicated concentrations of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid (Boehringer Mannheim) in PBS prior to addition of the substrate.
Haemagglutination and haemadsorption assays. Haemagglutination assays were performed as described previously (Herrler et al., 1985) .
Haemadsorption assays were carried out 2 days after infection with recombinant virus at 0 °C. Monolayers of infected Sf9 cells were washed once with PBS, and a 1% suspension of chick RBCs in saline was added. After 30 min, the cells were washed three times with PBS and examined microscopically. When the haemadsorption assay was performed in the presence of the neuraminidase inhibitor, the Sf9 cells were pretreated with a solution of 10 mM-2-deoxy-2,3-dehydro-Nacetylneuraminic acid in PBS for 1 h on ice. The supernatant was removed, and both the suspension of chick RBCs and PBS used for the washing steps were supplemented with 1 mM inhibitor. Results were recorded photographically.
To quantify haemadsorption, Sf9 cells in 4.8 cm Petri dishes were labelled with 100 gCi/ml [35S]methionine (Amersham) 48 h p.i. with recombinant baculovirus for 1 h after incubation without methionine for 30 min. Haemadsorption was performed with the labelled cells as described above. After the last wash the cells were lysed in 1 ml 0-5% Triton X-100, and a 100 gl aliquot was added to 2 ml of scintillant (Rotiszint Ecoplus). Radioactivity was determined in a Beckman 1801 liquid scintillation counter. The A540 of the rest of the lysate was measured in a Beckman DU-40 photometer. The ratio A540/c.p.m. was calculated to standardize A~40 for the number of cells, and the value for wild-type (wt) NA was set to 100 %.
Desialylation and resialylation of erythrocytes.
Chicken erythrocytes were incubated with NA from Vibrio cholerae (Behring) as described previously (Schultze et al., 1990) , and removal of endogenous sialic acid was checked by haemagglutination assay using FPV. Packed asialoerythrocytes (50 gl) were then resialylated as described by Paulson & Rogers (1987) using either 1 mU porcine liver Galfll-4GalNAc g2,3-sialyltransferase or 2mU rat liver Galfll-4GlcNAc g2,6-sialyltransferase and 170 nmol CMP-sialic acid (Boehringer Mannheim). Before being added, both enzymes were treated as previously described for Galfll-4GlcNAc g2,6-sialyltransferase (Schultze et al., 1990) .
Results
The FPV neuraminidase has catalytic and receptorbinding activities
To monitor the expression of NA in Sf9 cells by the recombinant baculovirus, the enzymatic activity was tested Concentration dependence of inhibition of neuraminidase activity by DANA. Sf9 cells were infected with recombinant baculovirus expressing NA, 48 h p.i. cell lysates were prepared and incubated with the respective final concentration of the NA inhibitor for 10 rain on ice immediately followed by neuraminidase assay as described above. as a substrate. As shown in Fig. 1 (a) NA activity is detectable in NA-expressing cells. The amount of liberated sialic acid increases with extended incubation times. The quantity of liberated fluorochrome after 10 min of incubation corresponds to an NA activity of 0"19 mU. When an equal amount of lysate from 10 ~ CV-1 cells infected with FPV for 6 h was assayed, the NA activity in this lysate was almost the same (0"17 mU per 1/100 vol. of cell lysate) indicating that the NA expressed in the insect cells has very similar kinetic properties to the authentic NA expressed from influenza virus. Further- more, NA activity was effectively inhibited by 10 mN-2-deoxy-2,3-dehydro-N-acetylneuraminic acid (DANA). The inhibition observed is nearly complete using DANA at a final concentration of 500 laM and decreases with lower concentrations of DANA (Fig. 1 b) .
The specificity of NA towards e2,3-or ~2,6-1inked neuraminic acid was also tested using 3'-N-acetylneuraminyl-lactose and 6'-N-acetylneuraminyl-lactose as substrates. The liberated sialic acid was detected by the thiobarbituric acid method. Baculovirus-expressed NA cleaved e2,3-1inked substrate 16 times more efficiently than e2,6-1inked neuraminic acid. NA in FPV particles or in FPV-infected cells also showed a clear preference for ~2,3-1inked sialic acid in this assay (data not shown). These results indicate that NA expressed by the baculovirus vector has very similar enzymatic properties to authentic NA from FPV.
When Sf9 cells infected with recombinant baculovirus expressing NA were tested for haemadsorption with chick erythrocytes, an unexpected observation was made: the cells showed strong haemadsorption (Fig. 2 d) . The capacity of NA-expressing cells to bind chick erythrocytes was as high as that of cells expressing the haemagglutinin of FPV (Fig. 2 c, d ). In order to identify the receptor on the erythrocytes, RBCs from chicks were freed from sialic acid by incubation with V. cholerae neuraminidase. Haemadsorption was almost completely abolished by this treatment (Fig. 2b) indicating that sialic acid is the determinant on the erythrocyte surface that is recognized by NA. NA-expressing Sf9 cells preincubated with anti-NA antibodies showed drastically reduced haemadsorption (Fig. 2h) , whereas insect cells expressing FPV HA subjected to the same procedure were still heavily loaded with erythrocytes (Fig. 2g) . Thus, it is clear that the observed haemadsorption is a genuine property of NA. When the haemadsorption assay was performed in the presence of the inhibitor DANA, NA still had haemadsorbing activity (Fig. 2f) . DANA binds to the enzyme active centre thereby inhibiting binding and subsequent hydrolysis of substrate. However, regardless of the blocked catalytic site, FPV NA is obviously able to bind erythrocytes suggesting that the binding site responsible for erythrocyte attachment activity is separate from the catalytic centre responsible for the enzymatic activity.
In an attempt to further characterize the receptor determinant recognized by FPV NA, asialo-erythrocytes were resialylated using ~2,3-or c~2,6-sialyltransferase by the procedure described by Schultze et al. (1990) . With the resialylated erythrocytes haemadsorption was partially restored (Fig. 3) . Concerning haemadsorbing activity, the FPV NA seemed to have a slight preference for e2,6-bound sialic acid, although the difference was not pronounced. However, haemadsorption activity with resialylated erythrocytes was significantly lower than with untreated chick erythrocytes. By counting all Sf9 cells and bound erythrocytes in a field of defined area, the number of bound untreated erythrocytes per Sf9 cell was approximately fivefold higher than the number of bound resialylated erythrocytes per cell. We conclude that the surface determinant recognized by FPV NA is sialic acid, because treatment with V. cholerae neuraminidase greatly reduced haemadsorption of chick erythrocytes which could in part be restored by the reconstitution of sialic acid on the erythrocyte surface. The low efficiency of restoration of haemadsorption activity using resialylated erythrocytes is discussed below.
Site-directed mutagenesis reveals distinct epitopes for receptor binding and catalytic activities
To further prove the existence of two sites reacting with sialic acid we modified FPV NA by site-directed mutagenesis. Two mutated NAs were constructed in which the suspected haemadsorbing site was altered. Mutated NA 1066 had the amino acid substitution S 345 to L. Mutated NA 1161 had the exchanges T375D37nw 37v to DNR (Table 1) . According to the observations made on the N2 neuraminidase (Nuss & Air, 1991) , these exchanges should abolish haemadsorbing activity, yet still allow correct folding and intracellular transport of the molecule. The substituted amino acids are located on two peptide loops exposed on the surface of the NA molecule. Amino acid S ~45 is located on the peptide loop designated as the first loop; amino acids T37~D376W 377 belong to the second loop. Additionally, we constructed two other * Amino acid positions are according to N2 numbering; positions with identical residues between N 1 and N9 as well as the corresponding residues in N2 are in bold. mutated NAs, each one with an amino acid substitution known to abolish the enzymatic activity of the molecule (Lentz et al., 1987) , in order to determine the influence of this activity on haemadsorption. R 152 was exchanged to K (mutated NA 419) and W 178 to S (mutated NA 501) ( Table 1) .
The haemadsorbing activity of mutated NAs 419 and 501 as judged by optical analysis was similar to that of NA wt (Fig. 4a) . In contrast, mutated NAs 1066 and 1161 were found to have almost completely lost their ability to cause haemadsorption (Fig. 4 a) , although they were present on the erythrocyte cell surface as demonstrated by surface immunofluorescence (Fig. 4b) . Quantification of haemadsorption of wt and mutated NAs by measuring haemoglobin of attached erythrocytes (Fig. 5a ) essentially reflected the results of the optical analysis: mutant 419 and the NA wt have comparable haemadsorbing activities, and mutated NA 501 has somewhat lower, but still distinct activity. In contrast, the ability of mutated NAs 1066 and 1161 to bind erythrocytes is markedly reduced to about 14% compared to the wt. The differences in HA activity between wt and mutated NAs were not due to a different expression level or altered transport kinetics. Immunoprecipitation of radiolabelled NA demonstrated that almost equal amounts of wt and mutated NAs were present in the cells (Fig. 6) . FPV NA expressed in insect cells has an apparent molecular mass in SDS-PAGE of about 52 kDa which is in accordance with the calculated value for the polypeptide backbone modified with three shortened oligosaccharides typical for insect cells. Furthermore, resistance to endoglucosaminidase H was acquired in the same period of time (Fig. 6) . Unlike the reduced haemadsorbing activity of mutants 1066 and 1161, the enzyme activity was not affected and was comparable to that of the wt and mutated NA 419 (Fig. 5 b) . Enzyme activity was tested using 3'-N-acetylneuraminyl-lactose and 6'-N-acetylneuraminyl-lactose as substrates combined with the thiobarbituric acid method allowing for discrimination of possibly altered substrate specificity of the mutated NAs. The results clearly demonstrate that neither the enzyme activity nor the substrate specificity of the mutated NAs are different from the wt. The wt and mutated NAs preferably cleave 0~2,3-1inked sialic acid to almost the same extent (Fig. 5b) , except for mutated NA 501 which has only residual NA activity in spite of its ability to induce haemadsorption. Interestingly, mutated NA 419 has wt levels of NA activity although the conserved R152 (N2 numbering) is replaced by a K residue which is reported to abolish NA activity (Lentz et al., 1987) . These observations again underline the fact that the two functions of the protein are independent and are therefore most probably located on separate domains of the molecule.
In order to investigate whether FPV and N9 NA are exceptions in having the amino acids that are crucial for this additional activity, we compared all available sequence data of influenza neuraminidases in the GenBank database (Table 2 a, b) . In the first loop, S in position 370 is conserved in almost all NA sequences known so far (Table 2 a). The surrounding sequence from amino acids 361-371 is also well conserved with R371 belonging to the catalytic centre. Considering the sequence data for the second loop, the most striking feature is the sequence similarity between N9 and N1 NAs concerning the peptide TDW at positions 401-403 which is present in all N9 and N1 sequences, except for the N1 NA of A/WSN/33. Secondly, the W residue at position 403 is found in almost all NA sequences (Table  2b ). The sequence comparison shows that the structural prerequisites that have so far been identified for a second sialic acid binding site are found in a number of other influenza A NAs, mainly of the N1 subtype.
Discussion
In the present study we report on the existence of a second biological activity of the N1 NA of A/FPV/ Rostock/34. We characterized this haemadsorbing acti-J. Hausmann and others Haemadsorption was carried out with the labelled cells as described in Methods. Quantification of radioactivity after the haemadsorption assay provided a measure of cell numbers. The amount of bound erythrocytes was determined by measuring the A540 of the released haemoglobin and was related to cell numbers. Results were corrected for background A54 o and the value for NA wt was set to 100%. (b) Neuraminidase activity of wt and mutated FPV NAs. Sf9 cells were mock-infected, infected with baculovirus recombinants expressing wt and mutated NAs or with baculovirus wt; 48 h p.i. cell lysates were prepared as described in Methods. A 1/100 volume of lysate per NA assay was used and the enzymatic activity towards c~2,3-and ~2,6-bound sialic acid was determined using 3'-N-acetylneuraminyl-lactose (3-NANL) or 6'-N-acetylneuraminyl-lactose (6-NANL). Liberated sialic acid was measured by the thiobarbituric acid assay.
vity using vector-expressed FPV NA in Sf9 cells and demonstrated that it is the result of binding of FPV NA to sialic acid containing glyco-conjugates. Binding was not blocked by the inhibitor DANA, which efficiently inhibited NA activity. Haemadsorbing activity of FPV NA was found not only in the insect cell system but also in the vertebrate cell line CV-1 when a vaccinia virus expression vector was used (data not shown). However, haemadsorbing activity of vaccinia virus-expressed NA was often difficult to distinguish from the endogenous haemagglutinating activity of the expression vector. We therefore concentrated on the baculovirus system in this study.
That the receptor-binding site of FPV NA interacts with sialic acid is clearly indicated by the observation that haemadsorption is abolished when erythrocytes are treated with V. cholerae neuraminidase. This concept is also supported by the finding that haemadsorption can be restored to some extent by resialylation. However, the low binding efficiency observed in these experiments suggests that c~2,3-and 0¢2,6-1inked N-acetylneuraminic acid and N-glycolylneuraminic acid are not the optimal receptors. The observation that erythrocytes adsorbed to Sf9 cells expressing NA do not elute at 37°C is compatible with this view. The exact type of sialic acid serving as the NA receptor remains therefore to be elucidated.
Location and critical amino acids of the receptor binding site and the catalytic site of the N1 neuraminidase
The hypothesis of a receptor binding site distinct from the catalytic site was verified by mutational analysis of FPV NA. The first type of mutated NAs with a single amino acid substitution that should affect NA activity (mutated NAs 419 and 501) was constructed to determine whether NA activity has an influence on the haemadsorbing activity of the molecule. For this purpose, two amino acids were chosen that met three conditions: both are known to be crucial for NA activity, their substitution by another amino acid does not affect transport efficiency (Lentz et al., 1987) , and they are located distantly from the putative binding site in the three-dimensional structure. Interestingly enough, only one of these two amino acids, W 17s (Fig. 7) seems to be important for enzymatic activity of FPV NA, although it should be noted that activity is not completely abolished when determined with the very sensitive assay with 4-methylumbelliferyl a-N-acetylneuraminic acid as substrate. The substitution R 1~2 to K (Fig. 7) has no significant effect on the enzymatic activity of mutated NA419. The proposed function for this amino acid is hydrogen bonding to the carbonyl group of the N-acetyl residue of sialic acid (Varghese et al., 1992) . b e e n s h o w n (Lentz et al., 1987) , the e n z y m a t i c properties of F P V m u t a t e d N A s u p p o r t this hypothesis.
T h e second type of m u t a t e d N A s (1066 a n d 1161) was intended to directly affect haemadsorbing activity by substitution of the amino acids that are identical with N9 NA and FPV NA at the putative binding site (Table 1) . As the haemadsorbing activity of those mutated NAs is almost lost, clear evidence for the existence of a second binding site is obtained. Exchange of the conserved S ~7° in FPV N1 NA has a great influence on RBC binding which emphasizes the importance of this amino acid on the first of the two surface loops for haemadsorbing activity of NA. Similarly, the minimum sequence requirement on the second loop of the receptor pocket of the FPV NA seems to be the TDW 4°1-4°3 peptide. It should be mentioned that the haemadsorbing activity of mutated NAs 1066 and 1161 is not completely abolished, which raises the possibility that additional and so far unidentified amino acids play a role in sialic acid binding.
The receptor pocket on the N9 molecule formed by the two surface loops discussed above is thought to be located on the rim of the crater representing the enzyme active centre (Fig. 7) . The three-dimensional structure of A/tern/Australia/G70C/75 N9 NA has been determined by X-ray crystallography. The computergenerated model of an N9 molecule deduced from these X-ray crystallographic data demonstrates the location of the haemadsorbing site very clearly (Fig. 7) . The receptor binding site and catalytic site are adjacent but not overlapping. Since the overall structures of all influenza A NAs are thought to be almost identical, the location and conformation of the putative receptor pocket in N1 NA is assumed to be very similar to the proposed one in A/tern/Australia/G70C/75 N9 NA.
Is a receptor binding site distinct from the catalytic centre a general property of the influenza A virus neur aminidase ?
The question of the biological significance of the additional haemagglutinating activity is still not solved. Early studies showed that haemagglutinating activity of the N9 NA is unable to complement infectivity when the virus is treated with neutralizing antibodies against HA (Laver et al., 1984) . This finding may suggest that haemagglutinating activity of NA has no functional importance for the influenza virus. However, the question still remains why this activity has been conserved in the N9 subtype and at least one strain of the N1 subtype.
The sequence similarities found in a number of influenza A NAs in the amino acid positions that are important for binding activity of the haemadsorbing NAs might indicate that not only N9 or FPV NA but also other N 1 NAs and perhaps NAs from other subtypes such as N2, N5 or N7 have binding activity for sialic acids or other ligands. A second possibility is that these conserved amino acids are remnants of a binding site which is no longer active due to mutational changes of amino acids in positions crucial for binding activity. The findings of the sequence comparison may reflect the derivation of NA of influenza viruses from a common ancestor which could have been an HN protein. There is considerable evidence for Sendai virus that the two functions of its HN protein reside in different sites of the molecule (Portner, 1981; Ray et al., 1992; Takahashi & Portner, 1992) although it should be noted that a single point mutation in the HN of Newcastle disease virus has been shown to affect both activities (Sheehan & Iorio, 1992). Nevertheless, several other lines of evidence support the structural separation of the two activities (Jorgensen et al., 1987) . Recently, it was demonstrated that there is a close relationship between the influenza virus NA and the HN protein of paramyxoviruses concerning the three-dimensional structure and the functional amino acids of the enzyme active site (Colman  et al., 1993) .
In the present study, N1 NA of FPV has been demonstrated to possess a sialic acid binding activity residing in a second binding pocket similar to the one found in the N9 subtype. Whether HA activity is a unique feature of FPV NA and the N9 NAs remains to be determined.
